• 1
    Record CO. Neurochemistry of hepatic encephalopathy. Gut 1991; 32: 12611263.
  • 2
    Rikkers L, Jenko P, Rudrman D, Freides D. Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology 1978; 75: 462469.
  • 3
    Marchesini G, Zoli M, Dondi C, Cecchini L, Angiolini A, Bianchi FB, Pisi E, et al. Prevalence of subclinical hepatic encephalopathy in cirrhotics and relationship to plasma amino acid imbalance. Dig Dis Sci 1980; 25: 763768.
  • 4
    Loguercio C, Del Vecchio Blanco C, Coltorti M. Oral ammonia load in well-compensated cirrhosis: effect on psychometric tests. In: BengtssonF, JeppssonB, AlmdalT, VilstrupH, eds. Progress in Hepatic Encephalopathy and Metabolic Nitrogen Exchange. Boca Raton: CRC Press, 1991: 8389.
  • 5
    Lacey JM, Wilmore DW. Is glutamine a conditionally essential amino acid? Nutr Rev 1990; 48: 297309.
  • 6
    Dechelotte P, Darmaun D, Rongier M, Hecketsweiler B, Rigal O, Desjeux J. Absorbtion and metabolic effects of enterally administered glutamine in humans. Am J Physiol 1991; 260: G677G682.
  • 7
    Souba WW, Smith RJ, Wilmore DW. Glutamine metabolism by the intestinal tract. JPEN J Parenter Enteral Nutr 1985; 9: 608617.
  • 8
    Wechsler D WAIS-R Manual. 1981 Psychological Corporation, New York.
  • 9
    Conn H. O. The trailmaking and number connection tests in the assessment of mental state in portalsystemic encephalopathy. Am J Dig Dis 1977; 22: 541550.
  • 10
    Davies A. The influence of age on trail making test performance. J Clin Psychol 1968; 24: 9698.
  • 11
    Coughlan A, Hollows S. Manual for the AIMPB. 1985, St. James Hospital, Leeds, UK.
  • 12
    Frewer LJ, Hindmarch I. The effects of time of day, age and anxiety on a choice reaction task. In: HindmarchI, AufdembrinkeB, OttH, eds. Psychopharmacology and Reaction Time. Chichester: John Wiley and Sons, 1988: 103114.
  • 13
    Prior PF, Maynard DE. Monitoring cerebral function. Long-term monitoring of EEG and evoked potentials. Amsterdam: Elsevier, 1986;
  • 14
    Gilberstadt SJ, Gilberstadt H, Zieve L, Buegel B, Collier RO, McLain CJ. Psychomotor performance defects in cirrhotic patients without overt encephalopathy. Arch Intern Med 1980; 140: 519521.
  • 15
    Gitlin N, Lewis DC, Hinkley L. The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. J Hepatol 1986; 3: 7582.
  • 16
    Moore JW, Dunk AA, Crawford JR, Deans H, Besson JA, De Lacey G, Sinclair TS, et al. Neuropsychological deficits and morphological MRI brain scan abnormalities in apparently healthy non-encephalo-pathic patients with cirrhosis. A controlled study. J Hepatol 1989; 9: 319325.
  • 17
    Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, Levy LL. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977; 72: 573583.
  • 18
    Quero Jc, Hartmann Ijc, Meulstee J, Hop Wcj, Schalm Sw. The diagnosis of subclinical hepatic-encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis. Hepatology 1996; 24: 556560.
  • 19
    Weissinborn K, Riikert N, Hecker H. Interindividual variability and clinical use of the number connection tests A and B. In: CapocacciaL, MerliM, RiggioO, eds. Advances in Hepatic Encephalopathy and Metabolic Nitrogen Exchange. Boca Raton, EL: CRC Press, 1995.
  • 20
    Kerr JS, Sherwood N, Hindmarch I. Separate and combined effects of the social drugs on psychomotor performance. Psychopharmacology 1991; 104: 113119.
  • 21
    Gabuzda D Jr, Philips GB, Davidson CS. Reversible toxic manifestations in patients with cirrhosis of the liver given cation-exchange resins. N Eng J Med 1952; 246: 124130.
  • 22
    Al-Mardini H, Leonard J, Bartlett K, Lloyd S, Record C. O.. Effect of methionine loading and endogenous hypermethioninaemia on blood mercaptans in man. Clin Chim Acta 1988; 176: 8390
  • 23
    Parsons-Smith BG, Summerskill WJH, Dawson AM, Sherlock S. The electroencephalogram in liver disease. Lancet 1957; 2: 867871.
  • 24
    van der Rijt CC, Schalm SW. Quantitative EEG analysis and evoked potentials to measure (latent) hepatic encephalopathy. J Hepatol 1992; 14: 141142.
  • 25
    Epstein CM, Riether AM, Henderson RM, Cotsonis GA. EEG in liver transplantation: visual and computerized analysis. Electroenceph Clin Neurophysiol 1992; 83: 367371.
  • 26
    Kennedy J, Parbhoo SP, MacGillivray B, Sherlock S. Effect of Extracorporeal Liver Perfusion on the Electroencephalogram of Patients in Coma due to Acute Liver Failure. Q J Med 1973; 167: 549561.
  • 27
    Teran JC, Mullen KD, McCullough AJ. Glutamin–a conditionally essential amino acid in cirrhosis? Am J of Clin Nutri 1995; 62 (5): 897900.